此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension

2019年11月14日 更新者:Profa. Dra. Vera Lúcia dos Santos Alves、Faculdade de Ciências Médicas da Santa Casa de São Paulo

Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension

Pulmonary hypertension (PH) features symptoms related to a decreased cardiac autonomic response, pulmonary function and exercise capacity.

Non-pharmacological interventions are low cost and can significant enhance outcomes in these patients. Neuromuscular electrical stimulation (NMES) has been proposed as a viable therapeutic approach in patients with functional limitations, particularly those that present with difficulty to perform exercise protocols.

Objective: to evaluate the impact of NMES on exercise capacity, spirometry values and quality of life of patients with PH.

Material and methods: prospective randomized controlled study with a control group (GC, n9) and NMES goup (GE, n8). Quality of life and exercise capacity through the six-minute walk test (6MWT) were assessed before and after the NMES protocol.

Results: the GE presented with a significant improvement in distance walked in the 6MWT, cycle ergometry, spirometry and quality of life in the areas of vitality, emotional and social aspects of the questionnaire Short Form Health Survey-36.

Conclusion: NMES is a useful tool in the treatment of patients with PH, resulting in improved exercise capacity, quality of life and lung function testing.

研究概览

地位

完全的

研究类型

介入性

注册 (实际的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Sao Paulo、巴西、01221-020
        • Santa Casa of Sao Paulo Medical School

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

Males and females greater than or equal to 18 years of age, clinically stable with optimized drug therapy in the last 3 months, previously diagnosed with a mean pulmonary arterial pressure ≥ 25 mmHg by right heart catheterization and who agreed to participate by signing an informed consent were included.

Exclusion Criteria:

Exclusion criteria included a diagnosis of Down syndrome, orthopedic disease or neurologic or diagnoses, history of acute heart attack, use of beta-blockers, any urgent or elective surgical intervention during the implementation of the protocol, those who used assistive devices to ambulate or develop an infectious process during the study protocol.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
无干预:Control Group (GC)
The GC received standard ambulatory care, including routine exams and drug therapy. All patients were reassessed after the 2 month protocol.
实验性的:NMES Group (GE)
Receiving the usual care and guidance on their illness, underwent 30 minute NMES sessions twice a week for two months using an electrostimulator. Specifically, 5 cm adhesive surface electrodes in four alternate channels on the Rectus Femoris (two channels the right and two on the left) were used to deliver two-phase symmetrical currents, with a rectangular pulse wave at a frequency of 35 Hz and pulse duration of 250 μ. The time of ascent and descent was one second, contraction time was four seconds and relaxation was eight seconds.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Distance in six-minute walk test
大体时间:change from baseline in distance at 2 months
analysis of distance
change from baseline in distance at 2 months
Oxygen saturation in six-minute walk test
大体时间:change from baseline in oxygen saturation at 2 months
analysis of oxygen saturation at end of test
change from baseline in oxygen saturation at 2 months
Systolic blood pressure in six-minute walk test
大体时间:change from baseline in systolic blood pressure at 2 months
analysis of systolic blood pressure at end of test
change from baseline in systolic blood pressure at 2 months
Diastolic blood pressure in six-minute walk test
大体时间:change from baseline in diastolic blood pressure at 2 months
analysis of diastolic blood pressure at end of test
change from baseline in diastolic blood pressure at 2 months
Heart rate in six-minute walk test
大体时间:change from baseline in heart rate at 2 months
analysis of heart rate at end of test
change from baseline in heart rate at 2 months
Borg scale in six-minute walk test
大体时间:change from baseline in Borg scale at 2 months
analysis of Borg scale at end of test
change from baseline in Borg scale at 2 months

次要结果测量

结果测量
措施说明
大体时间
The Medical Outcomes Study 36-item Short Form Health Survey
大体时间:change from baseline at 2 months
The questionnaire covers 36 items, designed to assess health concepts
change from baseline at 2 months
Forced vital capacity
大体时间:change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Forced expiratory volume in the first second
大体时间:change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Forced expiratory flow 25-75 %
大体时间:change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Ratio of forced expiratory volume in the first second and forced vital capacity
大体时间:change from baseline at 2 months
spirometric analysis
change from baseline at 2 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2014年6月1日

初级完成 (实际的)

2016年6月1日

研究完成 (实际的)

2016年12月1日

研究注册日期

首次提交

2016年3月8日

首先提交符合 QC 标准的

2016年3月14日

首次发布 (估计)

2016年3月18日

研究记录更新

最后更新发布 (实际的)

2019年11月18日

上次提交的符合 QC 标准的更新

2019年11月14日

最后验证

2016年2月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅